Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

EPIDEMIOLOGICAL AND CLINICAL ASPECTS OF RETINOBLASTOMA IN DEVELOPING COUNTRY

View through CrossRef
Introduction: Retinoblastoma is the most common intraocular tumor in child. Treatment depend on stadification and classification of retinoblastoma. The aim of this study was to describe epidemiological and clinical aspects of retinoblastoma in Madagascar. Method: We report in this retrospective study 44 cases found during 5 years, from January 2015 to December 2019. We have collected information about epidemiological and clinical aspect, delay of diagnosis. Classification of retinoblastoma was done with Reese Ellsworth classification and International Classification of Intra-ocular Retinoblastoma (ICRB). Data was collected with excel software and analysis was done with R-studio 4.2.2 software. The quantitative variables were expressed as an average and the qualitative variables as a proportion and percentage. Result: We had collected 44 cases. The incidence was 8.8 cases per year. Sex ratio was 1.3. Mean age was 40 months. Exophthalmos was found in 35% (n=12) of cases. Leukocoria was found in 24% (n=11) children. The delay time before diagnosis was 13 months. In 97.7% of cases, the retinoblastoma was unilateral. Intraocular form was found in 23 patients (52.3%). Among intraocular form 13 patients (57%) presented with grade E, including one patient with meningeal extension 9 patients (39%) with grade D, 1 patient (4%) in grade B. Extra ocular form was found in 21 patients (47.7%) : 17 (77%) had orbital invasion (stage III), 4 (23%) were metastatic (stage IV). Conclusion: Diagnosis of retinoblastoma was made in advanced stage. Most of patients had extraocular form. Prognosis was worse in Madagascar. Making diagnosis early is necessary to prevent loss of life.
Title: EPIDEMIOLOGICAL AND CLINICAL ASPECTS OF RETINOBLASTOMA IN DEVELOPING COUNTRY
Description:
Introduction: Retinoblastoma is the most common intraocular tumor in child.
Treatment depend on stadification and classification of retinoblastoma.
The aim of this study was to describe epidemiological and clinical aspects of retinoblastoma in Madagascar.
Method: We report in this retrospective study 44 cases found during 5 years, from January 2015 to December 2019.
We have collected information about epidemiological and clinical aspect, delay of diagnosis.
Classification of retinoblastoma was done with Reese Ellsworth classification and International Classification of Intra-ocular Retinoblastoma (ICRB).
Data was collected with excel software and analysis was done with R-studio 4.
2.
2 software.
The quantitative variables were expressed as an average and the qualitative variables as a proportion and percentage.
Result: We had collected 44 cases.
The incidence was 8.
8 cases per year.
Sex ratio was 1.
3.
Mean age was 40 months.
Exophthalmos was found in 35% (n=12) of cases.
Leukocoria was found in 24% (n=11) children.
The delay time before diagnosis was 13 months.
In 97.
7% of cases, the retinoblastoma was unilateral.
Intraocular form was found in 23 patients (52.
3%).
Among intraocular form 13 patients (57%) presented with grade E, including one patient with meningeal extension 9 patients (39%) with grade D, 1 patient (4%) in grade B.
Extra ocular form was found in 21 patients (47.
7%) : 17 (77%) had orbital invasion (stage III), 4 (23%) were metastatic (stage IV).
Conclusion: Diagnosis of retinoblastoma was made in advanced stage.
Most of patients had extraocular form.
Prognosis was worse in Madagascar.
Making diagnosis early is necessary to prevent loss of life.

Related Results

Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib
Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib
Chemotherapy remains the main approach conserving vision during the treatment of retinoblastoma, the most prevalent eye cancer in children. Unfortunately, the development of chemor...
Neonatal retinoblastoma: a brief report from the Malaysian Retinoblastoma Registry
Neonatal retinoblastoma: a brief report from the Malaysian Retinoblastoma Registry
Neonatal retinoblastoma is more widely reported in developed countries than in developing countries. We have conducted a retrospective case series to understand the nature of neona...
Molecular Genetics Mutations of Retinoblastoma
Molecular Genetics Mutations of Retinoblastoma
Retinoblastoma is a cancer that arises because both copies of the RB1 gene that normally suppresses retinoblastoma are lost from a developing retinal cell in fetuses, babies, and y...
Clinical Presentation of Retinoblastoma in Ethiopia: A Case of Jimma University Medical Center Pediatric Oncology Unit, Southwest Ethiopia
Clinical Presentation of Retinoblastoma in Ethiopia: A Case of Jimma University Medical Center Pediatric Oncology Unit, Southwest Ethiopia
BACKGROUND፡ Retinoblastoma (RB) is one of the most curable childhood cancers if early detected and treated. Late presentation complicates the management of RB results in dismal tre...
An Eye Opener: Lessons Learnt in Retinoblastoma Awareness and Screening Program
An Eye Opener: Lessons Learnt in Retinoblastoma Awareness and Screening Program
Background: Retinoblastoma is most common intraocular malignancy of infancy. Globally screening is recommended for ‘at risk’ children. Despite knowing this, Indian Cancer Society u...
Topotecan Combination Chemotherapy in Two New Rodent Models of Retinoblastoma
Topotecan Combination Chemotherapy in Two New Rodent Models of Retinoblastoma
AbstractChemotherapy combined with laser therapy and cryotherapy has improved the ocular salvage rate for children with bilateral retinoblastoma. However, children with late-stage ...
Retinoblastoma Research in Africa: A Scoping Review
Retinoblastoma Research in Africa: A Scoping Review
ABSTRACTAchieving equity in childhood cancer represents a global challenge. In Africa, where retinoblastoma has high mortality and morbidity, strengthening research capacity is cru...

Back to Top